{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:29:08Z","timestamp":1794360548726,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite extensive HBV vaccination efforts in Indonesia, the prevalence of occult hepatitis B virus infection (OBI) remains a concern, particularly among blood donors. This study investigated the prevalence of OBI, the distribution of circulating HBV genotypes, seropositivity for HBV-specific antibodies, and the potential influence of mutational characteristics on HBsAg secretion among blood donors in Jember, Indonesia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 330 HBsAg-negative blood donor samples from the Indonesian Red Cross in Jember were analyzed for HBV serological markers. Qualitative nested PCR and quantitative real-time PCR were used to detect HBV viral DNA and to measure viral load, respectively. HBV genotyping in positive samples was performed using Sanger sequencing of the S gene fragment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis revealed an OBI prevalence of 3%. Serological testing indicated that 27% of participants were positive for anti-HBs antibodies, 18% for anti-HBc, and 6% for anti-HBc alone. All HBV DNA-positive cases belonged to genotype B, primarily sub genotypes B3 and B4. Phylogenetic analysis revealed multiple mutations in the HBV surface (S) gene and the reverse transcriptase (RT) domain of the polymerase (Pol) protein, including immune escape mutations, suggesting potential risks for HBV transmission and reactivation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings emphasize the need for enhanced screening, including NAT alongside serological testing, to mitigate OBI risks in blood donors and improve transfusion safety and public health policies in HBV-endemic regions of Indonesia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11864-9","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:01:51Z","timestamp":1761904911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of occult hepatitis B infection and hepatitis B genotype characterization among blood donors in Jember Regency, East Java, Indonesia"],"prefix":"10.1186","volume":"25","author":[{"given":"Valentinus Dave","family":"Sugiharto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhane","family":"Hafza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noer Sidqi","family":"Muhammadiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rini","family":"Riyanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Chi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao Thi","family":"Huyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truong Nhat","family":"My","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Thi Thanh","family":"Huyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Huu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartika","family":"Senjarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumalaisamy P.","family":"Velavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"11864_CR1","unstructured":"WHO. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva; 2024. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"issue":"2","key":"11864_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2252326","volume":"55","author":"S Xiao","year":"2023","unstructured":"Xiao S, Xie W, Zhang Y, Lei L, Pan Y. Changing epidemiology of cirrhosis from 2010 to 2019: results from the global burden disease study 2019. Ann Med. 2023;55(2):2252326.","journal-title":"Ann Med"},{"issue":"1","key":"11864_CR3","first-page":"25","volume":"1","author":"N Saba","year":"2023","unstructured":"Saba N, Nisar M, MuhammadI-Saeed M, Wazeer A, Shaheen Z, Shah TH, et al. Performance evaluation of in vitro screening kits for hepatitis B in Resource-Limited settings. RADS JPharmAllied Health Sci. 2023;1(1):25\u20139.","journal-title":"RADS JPharmAllied Health Sci"},{"issue":"10","key":"11864_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0312126","volume":"19","author":"MN Mbencho","year":"2024","unstructured":"Mbencho MN, Hafza N, Cao LC, Mingo VN, Achidi EA, Ghogomu SM, et al. Incidence of occult hepatitis B infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon. PLoS ONE. 2024;19(10):e0312126.","journal-title":"PLoS ONE"},{"issue":"3","key":"11864_CR5","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v3i3.405","volume":"3","author":"BA Azhali","year":"2023","unstructured":"Azhali BA, Setiabudi D, Alam A. Evaluating the impact of triple elimination program for mother-to-child transmission of HIV, syphilis, and hepatitis B in Indonesia. Narra J. 2023;3(3):e405.","journal-title":"Narra J"},{"issue":"3","key":"11864_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s12072-010-9203-5","volume":"4","author":"MD Thedja","year":"2010","unstructured":"Thedja MD, Roni M, Harahap AR, Siregar NC, Ie SI, Muljono DH. Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol Int. 2010;4(3):608\u201314.","journal-title":"Hepatol Int"},{"issue":"8","key":"11864_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1473-3099(02)00345-6","volume":"2","author":"M Torbenson","year":"2002","unstructured":"Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2(8):479\u201386.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"11864_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJM199907013410104","volume":"341","author":"I Cacciola","year":"1999","unstructured":"Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999;341(1):22\u20136.","journal-title":"N Engl J Med"},{"issue":"12","key":"11864_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.4254\/wjh.v6.i12.860","volume":"6","author":"MS Kwak","year":"2014","unstructured":"Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol. 2014;6(12):860\u20139.","journal-title":"World J Hepatol"},{"issue":"5","key":"11864_CR10","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1128\/JCM.00145-11","volume":"49","author":"X Zheng","year":"2011","unstructured":"Zheng X, Ye X, Zhang L, Wang W, Shuai L, Wang A, et al. Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol. 2011;49(5):1730\u20137.","journal-title":"J Clin Microbiol"},{"key":"11864_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11121524","author":"TT Tung","year":"2022","unstructured":"Tung TT, Schmid J, Nghia VX, Cao LC, Linh LTK, Rungsung I, et al. Low risk of occult hepatitis B infection among Vietnamese blood donors. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11121524.","journal-title":"Pathogens"},{"issue":"7","key":"11864_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00705-009-0406-9","volume":"154","author":"SN Mulyanto, Depamede","year":"2009","unstructured":"Mulyanto, Depamede SN, Surayah K, Tsuda F, Ichiyama K, Takahashi M, et al. A nationwide molecular epidemiological study on hepatitis B virus in indonesia: identification of two novel subgenotypes, B8 and C7. Arch Virol. 2009;154(7):1047\u201359.","journal-title":"Arch Virol"},{"issue":"38","key":"11864_CR13","doi-asserted-by":"publisher","first-page":"10714","DOI":"10.3748\/wjg.v21.i38.10714","volume":"21","author":"Y Yano","year":"2015","unstructured":"Yano Y, Utsumi T, Lusida MI, Hayashi Y. Hepatitis B virus infection in Indonesia. World J Gastroenterol. 2015;21(38):10714\u201320.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"11864_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.4269\/ajtmh.15-0331","volume":"93","author":"SI Ie","year":"2015","unstructured":"Ie SI, Turyadi, Sidarta E, Sadhewa A, Purnomo GA, Soedarmono YS, et al. High prevalence of hepatitis B virus infection in young adults in Ternate, Eastern Indonesia. Am J Trop Med Hyg. 2015;93(6):1349\u201355.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"11864_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jmv.24045","volume":"87","author":"E Darmawan","year":"2015","unstructured":"Darmawan E, Turyadi, El-Khobar KE, Nursanty NK, Thedja MD, Muljono DH. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. J Med Virol. 2015;87(2):199\u2013207.","journal-title":"J Med Virol"},{"issue":"6","key":"11864_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7883\/yoken.JJID.2015.384","volume":"69","author":"AA Hadikusumo","year":"2016","unstructured":"Hadikusumo AA, Utsumi T, Amin M, Khairunisa SQ, Istimagfirah A, Wahyuni RM, et al. High rates of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus infections and uncommon HBV Genotype\/Subtype and HCV subtype distributions among transgender individuals in Surabaya, Indonesia. Jpn J Infect Dis. 2016;69(6):493\u20139.","journal-title":"Jpn J Infect Dis"},{"key":"11864_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/v13020346","author":"NX Hoan","year":"2021","unstructured":"Hoan NX, Hoechel M, Tomazatos A, Anh CX, Pallerla SR, Linh LTK, et al. Predominance of HBV genotype B and HDV genotype 1 in Vietnamese patients with chronic hepatitis. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13020346.","journal-title":"Viruses"},{"issue":"7","key":"11864_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131912","volume":"10","author":"OO Oluyinka","year":"2015","unstructured":"Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, et al. Occult hepatitis B virus infection in Nigerian blood donors and hepatitis B virus transmission risks. PLoS ONE. 2015;10(7):e0131912.","journal-title":"PLoS ONE"},{"issue":"8","key":"11864_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/jmv.23581","volume":"85","author":"HT Rinonce","year":"2013","unstructured":"Rinonce HT, Yano Y, Utsumi T, Heriyanto DS, Anggorowati N, Widasari DI, et al. Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: prevalence and molecular evidence for nosocomial transmission. J Med Virol. 2013;85(8):1348\u201361.","journal-title":"J Med Virol"},{"issue":"32","key":"11864_CR20","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.3748\/wjg.v22.i32.7264","volume":"22","author":"MI Lusida","year":"2016","unstructured":"Lusida MI, Juniastuti, Yano Y. Current hepatitis B virus infection situation in Indonesia and its genetic diversity. World J Gastroenterol. 2016;22(32):7264\u201374.","journal-title":"World J Gastroenterol"},{"key":"11864_CR21","unstructured":"Coalition for Global Hepatitis Elimination. Global Hepatitis. Global hepatitis elimination progress report: https:\/\/www.globalhep.org\/ (2024). Accessed 12 Feb 2025."},{"key":"11864_CR22","unstructured":"Health Ministry of Indonesia. National Action Plan for Hepatitis Prevention and Control. 2020. https:\/\/www.globalhep.org\/tools-resources\/action-plans\/action-plan-national-control-hepatitis-2020-2024."},{"key":"11864_CR23","unstructured":"WHO. Regional Action Plan for Viral Hepatitis in South-East Asia, 2016\u20132021 https:\/\/iris.who.int\/handle\/10665\/258735 (2016). Accessed 20 Oct 2024."},{"key":"11864_CR24","unstructured":": WHO. The Global Health Observatory, Hepatitis. https:\/\/www.who.int\/data\/gho\/data\/themes\/chronic-viral-hepatitis (2022). Accessed 20 Oct 2024."},{"issue":"12","key":"11864_CR25","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/gutjnl-2011-301281","volume":"61","author":"D Candotti","year":"2012","unstructured":"Candotti D, Lin CK, Belkhiri D, Sakuldamrongpanich T, Bisas S, Lin S, et al. Occult hepatitis B infection in blood donors from South East asia: molecular characterisation and potential mechanisms of occurrence. Gut. 2012;61(12):1744\u201353.","journal-title":"Gut"},{"issue":"1","key":"11864_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/vox.12073","volume":"106","author":"P Jutavijittum","year":"2014","unstructured":"Jutavijittum P, Andernach IE, Yousukh A, Samountry B, Samountry K, Thammavong T, et al. Occult hepatitis B infections among blood donors in Lao PDR. Vox Sang. 2014;106(1):31\u20137.","journal-title":"Vox Sang"},{"issue":"3","key":"11864_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4314\/ahs.v16i3.6","volume":"16","author":"SA Hudu","year":"2016","unstructured":"Hudu SA, Harmal NS, Saeed MI, Alshrari AS, Malik YA, Niazlin MT, et al. Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia. Afr Health Sci. 2016;16(3):677\u201383.","journal-title":"Afr Health Sci"},{"issue":"1","key":"11864_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","volume":"72","author":"EE Conners","year":"2023","unstructured":"Conners EE, Panagiotakopoulos L, Hofmeister MG, Spradling PR, Hagan LM, Harris AM, et al. Screening and testing for hepatitis B virus infection: CDC recommendations - United States, 2023. MMWR Recomm Rep. 2023;72(1):1\u201325.","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"11864_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/gene.2010.1","volume":"11","author":"S Davila","year":"2010","unstructured":"Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, et al. New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun. 2010;11(3):232\u20138.","journal-title":"Genes Immun"},{"issue":"3","key":"11864_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s11901-020-00522-0","volume":"19","author":"RG Gish","year":"2020","unstructured":"Gish RG, Basit SA, Ryan J, Dawood A, Protzer U. Hepatitis B core antibody: role in clinical practice in 2020. Curr Hepatol Rep. 2020;19(3):254\u201365.","journal-title":"Curr Hepatol Rep"},{"issue":"Suppl 1","key":"11864_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1440-1746.2010.06541.x","volume":"26","author":"CL Lin","year":"2011","unstructured":"Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol. 2011;26(Suppl 1):123\u201330.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"11864_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/jvh.13309","volume":"27","author":"H Wang","year":"2020","unstructured":"Wang H, Wang M, Huang J, Xu R, Liao Q, Shan Z, et al. Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection. J Viral Hepat. 2020;27(9):915\u201321.","journal-title":"J Viral Hepat"},{"issue":"2","key":"11864_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jmv.24623","volume":"89","author":"A Sadeghi","year":"2017","unstructured":"Sadeghi A, Shirvani-Dastgerdi E, Tacke F, Yagmur E, Poortahmasebi V, Poorebrahim M, et al. HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg. J Med Virol. 2017;89(2):246\u201356.","journal-title":"J Med Virol"},{"key":"11864_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104564","volume":"130","author":"J Wang","year":"2020","unstructured":"Wang J, Liu Y, Liao H, Liu L, Chen R, Si L, et al. The sK122R mutation of hepatitis B virus (HBV) is associated with occult HBV infection: analysis of a large cohort of Chinese patients. J Clin Virol. 2020;130:104564.","journal-title":"J Clin Virol"},{"key":"11864_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.754383","volume":"13","author":"X Ye","year":"2022","unstructured":"Ye X, Liu L, Chen L, Nie X, Huang L, Ye D, et al. High-frequency notable HBV mutations identified in blood donors with occult hepatitis B infection from Heyuan city of Southern China. Front Immunol. 2022;13:754383.","journal-title":"Front Immunol"},{"issue":"1","key":"11864_CR36","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1080\/22221751.2020.1757998","volume":"9","author":"R Salpini","year":"2020","unstructured":"Salpini R, Battisti A, Piermatteo L, Carioti L, Anastasiou OE, Gill US, et al. Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection. Emerg Microbes Infect. 2020;9(1):928\u201339.","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"11864_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2008.07.038","volume":"50","author":"V Svicher","year":"2009","unstructured":"Svicher V, Gori C, Trignetti M, Visca M, Micheli V, Bernassola M, et al. The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes. J Hepatol. 2009;50(3):461\u201370.","journal-title":"J Hepatol"},{"issue":"3","key":"11864_CR38","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/jac\/dkn207","volume":"62","author":"M Bottecchia","year":"2008","unstructured":"Bottecchia M, Madejon A, Sheldon J, Garcia-Samaniego J, Barreiro P, Soriano V. Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to Adefovir. J Antimicrob Chemother. 2008;62(3):626\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"11864_CR39","first-page":"9630","volume":"8","author":"X He","year":"2015","unstructured":"He X, Wang F, Huang B, Chen P, Zhong L. Detection and analysis of resistance mutations of hepatitis B virus. Int J Clin Exp Med. 2015;8(6):9630\u20139.","journal-title":"Int J Clin Exp Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11864-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11864-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11864-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:01:53Z","timestamp":1761904913000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11864-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11864"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11864-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee at the University of Jember, Indonesia, with the reference number 835\/UN25.1.10.2\/KE\/2024. All experiments were performed following guidelines and regulations. Informed consent was obtained from all the participants by the Indonesian Red Cross Jember Region.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1462"}}